IBP
BIndo-Bangla Pharmaceuticals Limited · Pharmaceuticals & Chemicals
No lists yet
Create on Stocks pageKey Statistics
Indo-Bangla Pharmaceuticals Limited
Pharmaceuticals & Chemicals sector stock listed on DSE since 2018.
Trading Info
Capital Structure
External Links
Valuation
Dividend History
Cash dividend declared, as a percentage of face value, with any bonus shares beside it. A dash means the year was not reported.
EPS History
Share Distribution
The company has informed that the Board of Directors has approved the appointment of Mr. Md. Shazzad Hossain as the Company Secretary of the Company.
The company has informed that the Board of Directors has approved the appointment of Mr. Md. Shazzad Hossain as the Company Secretary of the Company.
In response to a DSE query letter dated October 06, 2026 regarding a news published in an online news titled "Workers protest factory closure in Baris...
In response to a DSE query letter dated October 06, 2026 regarding a news published in an online news titled "Workers protest factory closure in Barishal" on September 24, 2026, the company has informed the following: "...on September 13, 2026, the factory operations were temporarily disrupted following an incident involving alleged verbal harassment of an officer of the Company by some workers. (cont.1) Following the said incident, upon conducting a proper investigation and taking lawful action, some workers who were found responsible created disorder within the factory premises and disrupted the normal production activities. In this regard, the Management took necessary lawful measures in accordance with the applicable laws and regulations. (cont.2) Subsequently, since September 27, 2026, the factory operations have been continuing peacefully and normally. The said incident has not had any adverse impact on the normal business operations of the Company, and there is no uncertainty regarding the going concern of the Company arising from the said matter."
(Q3 Un-audited): EPS was Tk. 0.01 for January-March 2026 as against Tk. (0.09) for January-March 2025; EPS was Tk. 0.02 for July 2025-March 2026 as ag...
(Q3 Un-audited): EPS was Tk. 0.01 for January-March 2026 as against Tk. (0.09) for January-March 2025; EPS was Tk. 0.02 for July 2025-March 2026 as against Tk. (0.17) for July 2024-March 2025. NOCFPS was Tk. 0.01 for July 2025-March 2026 as against Tk. 0.02 for July 2024-March 2025. NAV per share was Tk. 12.56 as on March 31, 2026 and Tk. 12.53 as on June 30, 2025. EPS improved due to higher revenue, improved gross profit, and better control over operating expenses during the period. NOCFPS decreased due to higher working capital requirements and increased operating cash payments in line with higher business activity. NAV per share slightly increased due to profit earned during the period.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
(Q2 Un-audited): EPS was Tk. 0.01 for October-December 2025 as against Tk. (0.05) for October-December 2024; EPS was Tk. 0.02 for July-December 2025 a...
(Q2 Un-audited): EPS was Tk. 0.01 for October-December 2025 as against Tk. (0.05) for October-December 2024; EPS was Tk. 0.02 for July-December 2025 as against Tk. (0.08) for July-December 2024. NOCFPS was Tk. 0.02 for July-December 2025 as against Tk. 0.03 for July-December 2024. NAV per share was Tk. 12.55 as on December 31, 2025 and 12.53 as on June 30, 2025. Reasons for deviations: EPS has increased mainly due to higher sales revenue, improved gross profit and better control over operating expenses during the period. NOCFPS decreased due to higher operating cash payments to suppliers, employees and other operating expenses during the period, deposit improved cash collections from customers.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.
(Q1 Un-audited): EPS was Tk. 0.01 for July-September 2025 as against Tk. (0.03) for July-September 2024. NOCFPS was Tk. 0.02 for July-September 2025 a...
(Q1 Un-audited): EPS was Tk. 0.01 for July-September 2025 as against Tk. (0.03) for July-September 2024. NOCFPS was Tk. 0.02 for July-September 2025 as against Tk. (0.06) for July-September 2024. NAV per share was Tk. 12.54 as on September 30, 2025 and Tk. 13.58 as on June 30, 2025. Reasons for deviation: EPS has improved to Tk. 0.01 from Tk. (0.03) in comparison to the same period of the previous year due to relatively improved operational performance, better cost control measures, and partial recovery in sales activities during the quarter. NOCFPS has increased to Tk. 0.02 from Tk. (0.06) compared to the same period of the previous year due to improved collection from customers and more efficient management of working capital, resulting in better operating cash inflows than the corresponding period.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 15, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2025.
The auditor of the company has given the Qualified Opinion, Emphasis of Matters and Material Uncertainty Related Going Concern paragraphs in the audit...
The auditor of the company has given the Qualified Opinion, Emphasis of Matters and Material Uncertainty Related Going Concern paragraphs in the audited financial statements of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Indo_2025.pdf
Momentum
Price ৳12.60-0.82 · signal -0.84 · hist +0.01
Price vs averages
Go Deeper on This Stock
RSI, MACD, Bollinger Bands, and 12+ indicators — calculated and ready for every listed stock.
Compare PlansBlock Trades
See What Big Investors Traded Today
Block transactions reveal institutional buying and selling that don't show up in regular price data.
Compare Plans